← FDA Drug Approvals (Drugs@FDA)
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2025-07-18
Drug application
- FDA Application #
ANDA207088- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- Generic name
- OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MACLEODS PHARMS LTD
- Manufacturer
- Macleods Pharmaceuticals Limited
- First approval
- 2025-07-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown